Attached files
| file | filename |
|---|---|
| EX-31.1 - EXHIBIT-31.1 - Gala Pharmaceutical Inc. | exhibit31-1.htm |
| 10-Q - GALA GLOABAL INC., 10-Q - Gala Pharmaceutical Inc. | glag-20160331_10q.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Calvin Frye, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
| (1) | the Quarter Report on Form 10-Q of Gala Global Inc. for the quarter ended May 31, 2016 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Gala Global Inc. |
| Dated: July 15, 2016 | ||||
| /s/Calvin Frye | ||||
| Calvin Frye | ||||
| Chief Executive Officer, Chief Financial Officer, and Director | ||||
| (Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer) | ||||